Kurt A. Gustafson

2017 - Spectrum Pharmaceuticals

In 2017, Kurt A. Gustafson earned a total compensation of $1.9M as Executive Vice President and Chief Financial Officer at Spectrum Pharmaceuticals, a 80% increase compared to previous year.

Compensation breakdown

Bonus$237,500
Option Awards$343,300
Salary$500,000
Stock Awards$661,213
Other$124,965
Total$1,866,978

Gustafson received $661.2K in stock awards, accounting for 35% of the total pay in 2017.

Gustafson also received $237.5K in bonus, $343.3K in option awards, $500K in salary and $125K in other compensation.

Rankings

In 2017, Kurt A. Gustafson's compensation ranked 5,839th out of 14,666 executives tracked by ExecPay. In other words, Gustafson earned more than 60.2% of executives.

ClassificationRankingPercentile
All
5,839
out of 14,666
60th
Division
Manufacturing
2,125
out of 5,768
63rd
Major group
Chemicals And Allied Products
662
out of 2,074
68th
Industry group
Drugs
511
out of 1,730
71st
Industry
Pharmaceutical Preparations
405
out of 1,329
70th
Source: SEC filing on May 7, 2018.

Gustafson's colleagues

We found three more compensation records of executives who worked with Kurt A. Gustafson at Spectrum Pharmaceuticals in 2017.

2017

Rajesh Shrotriya

Spectrum Pharmaceuticals

Chief Executive Officer

2017

Joseph Turgeon

Spectrum Pharmaceuticals

Chief Executive Officer

2017

Thomas Riga

Spectrum Pharmaceuticals

Chief Operating Officer

News

You may also like